Russia Diabetes Nutrition Market Analysis and Value Forecast Snapshot by End-use Industry 2020-2026

Infinium Global Research’s recent report on the “Russia Diabetes Nutrition Market (By Mode of Administration (Enteral and Oral), By Form (Powder and Liquid), By Distribution Channel (Hospitals, Retail Pharmacies, and Online)) Global Industry Analysis, Trends, Size, Share and Forecasts to 2026” provides a comprehensive outline of the factors responsible for the growth of the market. Russia's diabetes nutrition market size is expected to reach USD 170 million in 2026, with a CAGR of 5.37% during the forecast period. Russia diabetes nutrition market grows with the cagr of 5.37% over the forecast period 2020-2026. "We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026."  The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/2361

Key players in the Russia diabetic nutrition market are focused on offering an array of products. Multinational players have a strong distribution network in Russia with their extensive product portfolios in the Diabetes Nutrition markets. Therefore, the barrier to entry for new players is very high as the initial cost of entering the market is high and there are influential players in the market. The key players in the Russia Diabetes Nutrition market are Nestle S.A, B. Braun Melsungen AG, Abbott Laboratories, Fresenius Kabi, and Danone (Nutrica).

The COVID-19 pandemic reached Russia with a slight delay compared to Europe and Asia. However, things worsened quickly and by the end of March, the number of COVID-19 cases was rising at an alarming pace. Further, the outbreak got even worse in the month of April 2020 as the number of daily new cases in Russia went from a still manageable less than 1,000 to over 12,000 at the end of the month. The COVID-19 pandemic has created a stressful mind among the people having a chronic disease such as diabetes connected to medicines and diagnostic tools.

The COVID-19 is likely to infect people having diabetes with a 50% higher risk as compared to those who do not have diabetes. The hospitals gave preference to COVID-19 cases over patients with other less-severe health conditions. Thus, the number of procedures performed on diabetes health conditions fell rapidly during the pandemic. However, COVID-19 is expected to be an opportunity for diabetes devices and the drug market, as the patients having diabetes are at a higher risk of getting COVID-19 infection.

Enquire Here Get Customization & Check Discount for Report @ https://www.infiniumglobalresearch.com/reports/request-discount/2361

Oral to Remain the Largest Preferred Mode of Administration for Russia Diabetes Nutrition Market

Russia's diabetes nutrition market by service type is segmented into enteral and oral. The oral segment holds the largest market share in the Russian diabetes nutrition market in 2019. Oral mode of administration is expected to remain dominant over the coming years as it is an effective and non-invasive solution to tackle diabetic-related malnutrition in patients.

Liquid Products Occupy the Largest Share in the Russia Diabetes Nutrition Market

The Russian market is dominated by the liquid products as a large number of aging baby boomers consume liquid nutritional products. Moreover, majority physicians also recommend liquid products for diabetes. However, the powder products will see a spike in demand over the forecast period as  various new  and innovative powder products  which are easy to consume enter the market at affordable costs.

Browse Complete Report@ https://www.infiniumglobalresearch.com/ireland/russia-diabetes-injection-pens-market

Companies Operating in the Russia Diabetes Nutrition Market Focusing on Product Portfolio Expansion

The Russian Diabetes Nutrition sector is a high-growth market. The market is consolidated due to the presence of a limited number of multinational companies. The key players in the Russian diabetes nutrition market are Nestle S.A, B. Braun Melsungen AG, Abbott Laboratories, Fresenius Kabi, and Danone (Nutrica). The extent of the competition present within these 5 players is also very high due to the similarity of their market position in the Russian marketplace. Among them, Abbott Laboratories held the largest market share in the Russian diabetes nutrition market. The company’s premium product offerings Glucerna®, particularly for responding to growing diabetes and obesity epidemic has a large number of Russian consumers. Apart from that, diabetic nutrition products from companies such as Nestle S.A, B. Braun Melsungen AG, Fresenius Kabi, and Danone(Nutrica) also has high acceptance among physicians.